Skip to main content
OSTEOPORE LIMITED logo

OSTEOPORE LIMITED — Investor Relations & Filings

Ticker · OSX ISIN · AU0000053324 ASX Manufacturing
Open in API
Filings indexed 488 across all filing types
Latest filing 2022-12-07 Capital/Financing Update
Country AU Australia
Listing ASX OSX

About OSTEOPORE LIMITED

https://osteopore.com

Osteopore Limited specializes in the design and manufacture of 3D-printed bioresorbable implants. The company utilizes a patented 3D printing process to create scaffolds from bioresorbable polymers, such as polycaprolactone, designed to mimic the natural microstructure of bone. These implants, including the Osteoplug, Osteomesh, and Osteostrip product lines, are applied in neurosurgical, craniofacial, and orthopedic procedures to facilitate bone healing and tissue regeneration. The scaffolds provide a temporary structural framework that supports the body's natural healing process before being gradually absorbed and replaced by the patient's own bone tissue. This technology aims to reduce long-term complications associated with permanent foreign implants by promoting natural tissue integration and restoration across various clinical applications.

Recent filings

Filing Released Lang Actions
Increased presence and commercial opportunities across SEA 4 pages 496.6KB
Capital/Financing Update Classification · 95% confidence The document is an ASX release announcing regulatory approval and a new distribution agreement for Osteopore Limited's products in Southeast Asia. It focuses on commercial opportunities, market entry, and partnership details. There are no financial statements, earnings data, or detailed financial analysis present. The content is typical of a Capital/Financing Update as it relates to business development and commercial expansion rather than a full financial report or earnings release. Therefore, the document fits best under Capital/Financing Update (CAP).
2022-12-07 English
Activities Update Qtr Ending September 2022 and Appendix 4C 10 pages 531.3KB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX release from Osteopore Limited reporting quarterly financial results and operational highlights for Q3 CY22, including revenue figures, cash flow statements, and business updates. It includes detailed financial data such as revenue growth, cash on hand, net cash used in operating activities, and an Appendix 4C cash flow report, which is a standard quarterly report required by the ASX Listing Rules. The presence of substantive financial data and analysis for a quarter shorter than a full fiscal year indicates this is an Interim / Quarterly Report. It is not merely an announcement of a report or a certification, but contains actual financial statements and operational commentary for the quarter ended 30 September 2022. Q3 2022
2022-10-30 English
Change in substantial holding 2 pages 233.5KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 filed under the Corporations Act 2001, Section 671B, titled 'Notice of change of interests of substantial holder.' It details changes in voting power and relevant interests of a substantial shareholder, Irene Ng Ai Chen, including dates and share quantities. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category 'Major Shareholding Notification' (MRQ). The document is short and focused solely on shareholding changes, not financial results or other report types.
2022-10-04 English
Ceasing to be a substantial holder 1 page 84.3KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 Notice of ceasing to be a substantial holder under the Corporations Act 2001 Section 671B. It details changes in relevant interests and voting securities of a substantial holder, Michael Marcus Liew, including dates and transaction types. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category Major Shareholding Notification (MRQ). The document length is short and focused solely on shareholding changes, not financial results or other report types.
2022-10-04 English
More Osteopore Products Available on Prostheses List 2 pages 251.9KB
Regulatory Filings Classification · 95% confidence The document is an ASX release announcing that Osteopore Limited's products have been added to the Australian Prostheses List, which is related to reimbursement eligibility under private health insurance. The content focuses on a regulatory and commercial update rather than financial results, management changes, or detailed financial data. The document is relatively short (3927 characters) and serves as a formal announcement of a business development rather than a report or detailed financial filing. It does not contain financial statements, earnings data, or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and compliance-related disclosures that do not fit other specific categories.
2022-09-27 English
Chile Government and University co-fund Osteopore research 3 pages 290.9KB
Capital/Financing Update Classification · 95% confidence The document is an ASX release announcing that Osteopore Limited has received non-dilutive grant funding to develop improved bone regeneration implants. It details the grant source, project goals, and strategic implications. There are no financial statements, earnings data, or detailed financial analysis. The document is a corporate announcement about a capital grant and research funding, not a financial report or regulatory filing. It does not fit categories like Annual Report, Earnings Release, or Management Reports. It is best classified as a Capital/Financing Update (CAP) because it announces funding received and related project development plans.
2022-09-27 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.